Hepatocellular carcinoma(HCC)is a grave primary liver cancer that has a limited therapeutic option because it is generally diagnosed later in an advanced stage
以研究发病或死亡为基础的前瞻性研究通常是以探索疾病危险因素或评价干预措施效果为目的,常缺乏对疾病负担的综合评估,不利于指导宏观卫生决策.失能调整生命年(disability adjusted life year,DALY)是将发病和死亡所致失能结合在一起反映疾病负担的一个综合指标,20世纪90年代以来已得到广泛应用[1-3].但DALY的计算是基于很多发病率、死亡率、平均病程等群体水平资料[4],
Post transplant lymphoproliferative disorder (PTLD) represents a life threatening disorder occurring after transplantation, ranging from a polyclonal mononucleo